Primary Central Nervous System Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis: Case Report and Review of Literature-Reference-Cited by-同舟云学术

Primary Central Nervous System Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis: Case Report and Review of Literature

Published:2020 Issue:3 Volume:7 Page:121-127
ISSN:2188-4226
Container-title:NMC Case Report Journal
language:en
Short-container-title:

Author:

Uneda Atsuhito¹²,Hirashita Koji¹,Kanda Takahiro¹,Yunoki Masatoshi¹,Yoshino Kimihiro¹,Kurozumi Kazuhiko²,Date Isao²

Affiliation:

1. Department of Neurosurgery, Kagawa Rosai Hospital, Marugame, Kagawa, Japan

2. Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Okayama, Japan

Publisher

Japan Neurosurgical Society

Subject

Polymers and Plastics,General Environmental Science

Link

https://www.jstage.jst.go.jp/article/nmccrj/7/3/7_cr.2019-0241/_pdf

Reference29 articles.

1. 1) Singh JA, Saag KG, Bridges SL Jr, et al: 2015 American College of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68: 1–26, 2016

2. 2) Ellman MH, Hurwitz H, Thomas C, Kozloff M: Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 18: 1741–1743, 1991

3. 3) Hoshida Y, Xu JX, Fujita S, et al.: Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 34: 322–331, 2007

4. 4) Gaulard P, Swerdlow SH, Harris NL, Sundstrom C, Jaffe ES: Other iatrogenic immunodeficiency associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, et al. (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed., Lyon, IARC, 462–464, 2017

5. 5) Salloum E, Cooper DL, Howe G, et al.: Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 14: 1943–1949, 1996

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methotrexate‑related other iatrogenic immunodeficiency‑associated lymphoproliferative disorder in the CNS and medication‑related osteonecrosis of the jaw occurring simultaneously: A case report;Experimental and Therapeutic Medicine;2023-11-28

2. Central Nervous System Lymphoproliferative Disorder Secondary to Methotrexate: A Systematic Literature Review and Case Illustration;World Neurosurgery;2023-11

3. 左手掌部に発生した稀な腫瘤の1例;Orthopedics & Traumatology;2023-03-25

4. A Case of Primary Central Nervous System Methotrexate-Associated Lymphoproliferative Disorder Treated Via R-MPV Therapy;Journal of Nihon University Medical Association;2023-02-01

5. Rituximab Monotherapy for Grade 2-3 Lymphomatoid Granulomatosis with Central Nervous System Involvement in a Patient Receiving Methotrexate for Rheumatoid Arthritis;Internal Medicine;2023